Universe Pharmaceuticals INC — All Filings
99 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
3
424B4
424B5
6-K
8-A12B
CERT
CORRESP
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
NT 20-F
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | CURRENT REPORT | 0001213900-23-042704 | May 24, 2023 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-23-036897 | May 5, 2023 | — |
| SC 13G/A | — | 0001590144-23-000013 | Feb 14, 2023 | — |
| 20-F | ANNUAL REPORT | 0001213900-23-010349 | Feb 10, 2023 | Sep 30, 2022 |
| NT 20-F | NOTIFICATION OF LATE FILING | 0001213900-23-006011 | Jan 30, 2023 | Sep 30, 2022 |
| EFFECT | — | 9999999995-22-003304 | Nov 15, 2022 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-22-071615 | Nov 14, 2022 | — |
| F-3 | REGISTRATION STATEMENT | 0001213900-22-066745 | Oct 27, 2022 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-22-059567 | Sep 28, 2022 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-22-051801 | Aug 29, 2022 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-22-048630 | Aug 16, 2022 | Mar 31, 2022 |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-22-040289 | Jul 19, 2022 | — |
| SC 13G | SCHEDULE 13G | 0001213900-22-006715 | Feb 11, 2022 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-22-004361 | Jan 31, 2022 | — |
| 20-F | ANNUAL REPORT | 0001213900-22-004359 | Jan 31, 2022 | Sep 30, 2021 |
| SC 13G | UPC PURA VIDA 13G | 0001590144-21-000023 | Dec 28, 2021 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-21-065462 | Dec 15, 2021 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-21-064704 | Dec 10, 2021 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-21-064420 | Dec 9, 2021 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-21-039706 | Aug 2, 2021 | — |
| 6-K | CURRENT REPORT | 0001213900-21-019252 | Mar 31, 2021 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-21-017756 | Mar 25, 2021 | — |
| 424B4 | PROSPECTUS | 0001213900-21-017519 | Mar 24, 2021 | — |
| EFFECT | — | 9999999995-21-001048 | Mar 22, 2021 | — |
| CERT | — | 0001354457-21-000375 | Mar 22, 2021 | — |
| CORRESP | — | 0001213900-21-016140 | Mar 17, 2021 | — |
| CORRESP | — | 0001213900-21-016138 | Mar 17, 2021 | — |
| 8-A12B | FORM 8-A12B | 0001213900-21-015993 | Mar 17, 2021 | — |
| CORRESP | — | 0001213900-21-014544 | Mar 10, 2021 | — |
| F-1/A | AMENDMENT NO. 4 TO FORM F-1 | 0001213900-21-014541 | Mar 10, 2021 | — |
| UPLOAD | — | 0000000000-21-002502 | Mar 2, 2021 | — |
| FWP | FREE WRITING PROSPECTUS | 0001213900-21-012481 | Mar 1, 2021 | — |
| FWP | FREE WRITING PROSPECTUS | 0001213900-21-012476 | Mar 1, 2021 | — |
| F-1/A | AMENDMENT NO. 3 TO FORM F-1 | 0001213900-21-011334 | Feb 24, 2021 | — |
| FWP | FREE WRITING PROSPECTUS | 0001213900-20-042016 | Dec 10, 2020 | — |
| CORRESP | — | 0001213900-20-040416 | Dec 2, 2020 | — |
| F-1/A | AMENDMENT NO.2 TO FORM F-1 | 0001213900-20-040413 | Dec 2, 2020 | — |
| UPLOAD | — | 0000000000-20-011085 | Nov 19, 2020 | — |
| CORRESP | — | 0001213900-20-037562 | Nov 17, 2020 | — |
| F-1/A | AMENDMENT NO. 1 TO FORM F-1 | 0001213900-20-037560 | Nov 17, 2020 | — |
| FWP | FREE WRITING PROSPECTUS | 0001213900-20-027968 | Sep 23, 2020 | — |
| UPLOAD | — | 0000000000-20-008230 | Sep 1, 2020 | — |
| CORRESP | — | 0001213900-20-022483 | Aug 17, 2020 | — |
| F-1 | REGISTRATION STATEMENT | 0001213900-20-022480 | Aug 17, 2020 | — |
| UPLOAD | — | 0000000000-20-005656 | Jun 24, 2020 | — |
| DRSLTR | — | 0001213900-20-014804 | Jun 12, 2020 | — |
| DRS/A | — | 0001213900-20-014802 | Jun 12, 2020 | — |
| UPLOAD | — | 0000000000-20-004524 | May 20, 2020 | — |
| DRS | — | 0001213900-20-010024 | Apr 24, 2020 | — |